Wilson Sonsini Goodrich & Rosati has advised Whitehawk Therapeutics. Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company, has announced that it has entered into a securities…
Whitehawk Therapeutics Announces $87.5 Million Private Placement Financing

























